Search results for "Enfermedades Cardiovasculares"

showing 10 items of 41 documents

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies

2019

[Background]: The pandemic of cardiovascular disease (CVD) and type 2 diabetes (T2D) requires the identification of new predictor biomarkers. Biomarkers potentially modifiable with lifestyle changes deserve a special interest. Our aims were to analyze: (a) The associations of lysine, 2-aminoadipic acid (2-AAA) or pipecolic acid with the risk of T2D or CVD in the PREDIMED trial; (b) the effect of the dietary intervention on 1-year changes in these metabolites, and (c) whether the Mediterranean diet (MedDiet) interventions can modify the effects of these metabolites on CVD or T2D risk. [Methods]: Two unstratified case-cohort studies nested within the PREDIMED trial were used. For CVD analyses…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemTime FactorsMediterranean dietEndocrinology Diabetes and MetabolismhumanosDiseaseType 2 diabetes030204 cardiovascular system & hematologyDiet Mediterraneanchemistry.chemical_compound0302 clinical medicineRisk Factorsestudios prospectivosevaluación de riesgosMetabolites030212 general & internal medicineProspective Studiesmediana edadOriginal InvestigationPipecolic acidRandomized Controlled Trials as TopicAged 80 and overancianodietaácidos pipecólicosensayos clínicos controlados aleatorizados como asuntoresultado del tratamientoIncidenceType 2 diabetesMiddle AgedCardiovascular disease3. Good healthPrimary PreventionTreatment OutcomeCardiovascular DiseasesPipecolic AcidsFemaleCardiology and Cardiovascular Medicineconducta de reducción del riesgoCohort studymedicine.medical_specialtyenfermedades cardiovascularesácido 2-aminoadípicoRisk Assessmentincidencia03 medical and health sciencesfactores de tiempoInternal medicineDiabetes mellitusmedicineDiabetes Mellitusfactores de riesgoHumansAngiologyAgedProportional hazards modelbusiness.industryLysinemedicine.diseaseDietlisinaDietary interventionchemistryDiabetes Mellitus Type 2lcsh:RC666-701business2-Aminoadipic AcidRisk Reduction BehaviorBiomarkers
researchProduct

Homocysteine and long-term recurrent infarction following an acute coronary syndrome.

2021

En Cardiology Journal. Gdańsk (Polonia) : Via Medica. Vol. 28, n. 4 (01 jul. 2021), pp. 598-606. ISSN 1897-5593. e-ISSN 1898-018X. Este artículo se encuentra disponible en la siguiente URL: https://journals.viamedica.pl/cardiology_journal/article/view/CJ.a2020.0170/52602 En este artículo de investigación también participan: Maria Marco, Teresa García-Ballester, Begoña Zorio, Eduardo Núñez, Francisco J. Chorro, Juan Sanchis y Julio Núñez. Background: There are no well-established predictors of recurrent ischemic coronary events after an acute coronary syndrome (ACS). Higher levels of homocysteine have been reported to be associated with an increased atherosclerotic burden. The primary endpoi…

Malemedicine.medical_specialtyAcute coronary syndromeHomocysteinemedicine.medical_treatmentCoronary heart disease - Risk factors.Infarto de miocardio - Factores de riesgo.Enfermedad coronaria - Factores de riesgo.InfarctionClinical CardiologyRevascularizationCoronary artery diseasechemistry.chemical_compoundInterquartile rangeRisk FactorsInternal medicineMyocardial infarction - Risk factors.medicineHumansMyocardial infarctionAcute Coronary SyndromeHomocysteineAgedacute coronary syndrome coronary artery disease homocysteine recurrent myocardial infarction risk factorsCardiovascular system - Diseases - Risk factors.Framingham Risk Scorebusiness.industryEnfermedades cardiovasculares - Factores de riesgo.General Medicinemedicine.diseaseHospitalizationchemistryCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessCardiology journal
researchProduct

Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial

2014

[Background] Polyphenols may lower the risk of cardiovascular disease (CVD) and other chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their beneficial effects on blood pressure, lipids and insulin resistance. However, no previous epidemiological studies have evaluated the relationship between the intake of total polyphenols intake and polyphenol subclasses with overall mortality. Our aim was to evaluate whether polyphenol intake is associated with all-cause mortality in subjects at high cardiovascular risk.

MaleriesgoMediterranean dietmodelos de riesgos proporcionaleshumanosPhysiologyDiet MediterraneanAntioxidantsRisk FactorsSistema cardiovascular--MalaltiesCause of DeathNeoplasmsflavonoidesEpidemiologyStilbenesHydroxybenzoates1741-7015mediana edadCause of deathAged 80 and overMedicine(all)neoplasiasancianodietaHazard ratiofood and beveragesGeneral MedicineMiddle AgedCardiovascular diseaseAll-cause mortalityMetabolismeCardiovascular DiseasesPolifenolsFemaleResearch ArticleRiskPREDIMEDmedicine.medical_specialtyenfermedades cardiovascularesLignansInsulin resistanceMediterranean cookingMedical statisticscausas de muertehidroxibenzoatosMediterranean dietCuina mediterràniaantioxidantesmedicineMortalitatHumansfactores de riesgoFood consumptionMortalitypolifenolesAgedProportional Hazards ModelsFlavonoidsProportional hazards modelbusiness.industryPolyphenolsPREDIMED studyPolyphenol intakemedicine.diseaseConfidence intervalBiotechnologyDietMetabolismPolyphenolCommentarybusinessEstadística mèdicaConsum d'aliments
researchProduct

Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk

2012

Introduction: Several anthropometric measurements have been associated with cardiovascular disease, type-2 diabetes mellitus and other cardiovascular risk conditions, such as hypertension or metabolic syndrome. Waist-to-height-ratio has been proposed as a useful tool for assessing abdominal obesity, correcting other measurements for the height of the individual. We compared the ability of several anthropometric measurements to predict the presence of type-2 diabetes, hyperglycemia, hypertension, atherogenic dyslipidemia or metabolic syndrome. Materials and Methods: In our cross-sectional analyses we included 7447 Spanish individuals at high cardiovascular risk, men aged 55-80 years and wome…

MaleriesgoNon-Clinical Medicineestatura corporalhumanosCardiovascularPersones gransBody Mass Indexconstitución corporalEndocrinologyRisk Factorsanálisis de regresiónOdds RatioAbdominal obesitymediana edadAged 80 and overWaist-to-height ratioancianoMultidisciplinaryAnthropometryQRMiddle Agedcociente de probabilidades relativasCardiovascular diseasesCardiovascular DiseasesObesity AbdominalHypertensionRegression AnalysisMedicineObesitatFemalemedicine.symptomWaist CircumferenceResearch ArticleRiskmedicine.medical_specialtyScienceenfermedades cardiovascularesInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansfactores de riesgoObesityRisk factorobesidadNutritionAgedDiabetic EndocrinologyElderly CareHealth Care Policyperímetro abdominalbusiness.industryMalalties cardiovascularsíndice de masa corporalnutritional and metabolic diseasesOdds ratioDiabetes Mellitus Type 2medicine.diseaseBody HeightEndocrinologyCross-Sectional StudiesDiabetes Mellitus Type 2antropometríaSpainGeriatricsMetabolic DisordersBody ConstitutionMetabolic syndromeOlder peoplebusinessBody mass indexDyslipidemiaestudios transversales
researchProduct

Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A c…

2017

Limited data exists on the interrelationships between physical activity (PA), sedentary behaviors and sleep concerning cardiometabolic risk factors in aged adults at high cardiovascular disease risk. Our aim was to examine independent and joint associations between time spent in leisure-time PA, sedentary behaviors and sleep on the prevalence of obesity, type 2 diabetes (T2D) and components of the metabolic syndrome (MetS) in Mediterranean individuals at high cardiovascular risk. Cross-sectional analyses were performed on baseline data from 5776 Spanish adults (aged 55-75y in men; 60-75y in women) with overweight/ obesity and MetS, from October 2013 to October 2016, in the PREDIMED-PLUS tri…

MalesueñoSíndrome metabòlicaSedentarisme (Medicina)EtiologyPhysiologyCross-sectional studyEpidemiologyhumanosSistema cardiovascular -- Malaltieslcsh:Medicineejercicio físicoBlood PressureType 2 diabetesWalkingCardiovascular Medicine030204 cardiovascular system & hematologyOverweightBiochemistryVascular MedicineDiabetis no-insulinodependentHàbits sanitaris0302 clinical medicineRisk FactorsEstà en blancMedicine and Health SciencesOdds RatioPrevalenceNon-insulin-dependent diabetesBiomechanicsPublic and Occupational Health030212 general & internal medicinelcsh:Sciencemediana edadAbdominal obesityMetabolic SyndromeBioquímica y tecnologíaancianoMultidisciplinaryFactors de risc en les malaltiesprevalenciaMiddle Agedcociente de probabilidades relativas1932-62033. Good healthBiochemistry and technologyPhysiological ParametersCardiovascular DiseasesEtiologiadiabetes mellitusHypertensionFemalemedicine.symptomResearch Articlemedicine.medical_specialtyRisk factors in diseasesenfermedades cardiovascularesExerciciBioenergeticsBioquímica i biotecnologia03 medical and health sciencesmedicinefactores de riesgoHumansObesityEpidemiologiaHealth behaviorExerciseAgedBehaviorBiological Locomotionbusiness.industryPhysical activityBody Weightlcsh:RBiology and Life SciencesPhysical ActivityOdds ratiomedicine.diseaseObesitySonSistema cardiovascular -- Malalties -- Factors de riscCross-Sectional StudiesDiabetes Mellitus Type 2SpainRelative riskPhysical therapylcsh:QSon -- Aspectes fisiològicsMetabolic syndromeSedentary BehaviorPhysiological ProcessesbusinessSleepBiomarkersestudios transversalesDemography
researchProduct

El estudio PROPRESE: resultados de un nuevo modelo organizativo en atención primaria para pacientes con cardiopatía isquémica crónica basado en una i…

2014

ResumenObjetivoComparando los resultados obtenidos en los estudios EUROASPIRE I y EUROASPIRE III en pacientes con cardiopatía isquémica se muestra que el grado de control de los factores de riesgo mayores es mejorable. El objetivo de este estudio es evaluar la eficacia de una intervención multifactorial orientada a la mejora del grado de control en estos pacientes en el ámbito de la atención primaria.MétodosEn este estudio de intervención aleatorizado, con 1 año de seguimiento, se reclutó a pacientes con diagnóstico de cardiopatía isquémica (145 en el grupo de intervención y 1.461 en el grupo control). Se aplicó una intervención organizativa mixta basada en la mejora de la relación profesio…

Medicine(all)lcsh:R5-920Cardiovascular diseasesSecondary preventionPrevención secundariaHealth services researchInvestigación en servicios sanitariosGeneral MedicineEnfermedades cardiovascularesPrimary careFamily PracticeAtención primarialcsh:Medicine (General)Atención Primaria
researchProduct

Low physical activity and its association with diabetes and other cardiovascular risk factors: a nationwide, population-based study

2016

Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion); Ministerio de Sanidad y Consumo; Spanish Diabetes Society (SED)

QuestionnairesMaleDislipidemiasCross-sectional studyEstudios transversalesEspañaObesidadÍndice de masa corporalBiochemistryBody Mass Index0302 clinical medicineEndocrinology:Phenomena and Processes::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Musculoskeletal Physiological Processes::Movement::Motor Activity [Medical Subject Headings]Public and Occupational Healthlcsh:Science:Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Diet Mediterranean [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence [Medical Subject Headings]:Chemicals and Drugs::Lipids::Glycerides::Triglycerides [Medical Subject Headings]:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]Aged 80 and overDiabetis:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Lipid Metabolism Disorders::Dyslipidemias [Medical Subject Headings]:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight::Obesity::Obesity Abdominal [Medical Subject Headings]Cardiovascular DiseasesObesitatEnfermedades cardiovascularesFactores de riesgomedicine.medical_specialtyEndocrine Disorders:Chemicals and Drugs::Lipids::Lipoproteins::Lipoproteins HDL::Cholesterol HDL [Medical Subject Headings]:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Habits::Smoking [Medical Subject Headings]QüestionarisTriglicéridosExercici -- Aspectes sanitaris03 medical and health sciencesDiabetes MellitusHumans:Diseases::Cardiovascular Diseases [Medical Subject Headings]ExerciseAgedSurvey ResearchMalalties cardiovascularsPreventionlcsh:REnfermedad crónicaBiology and Life SciencesPhysical ActivityInsulin-resistancemedicine.diseaseActividad motoraObesityLipid metabolismCross-Sectional StudiesDyslipidemiaAdherenceGlucosalcsh:QBody mass indexDyslipidemiaDemography:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style::Sedentary Lifestyle [Medical Subject Headings]PhysiologyPhysical fitnessSistema cardiovascular -- Malalties:Chemicals and Drugs::Carbohydrates::Monosaccharides::Hexoses::Glucose [Medical Subject Headings]lcsh:Medicine:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight::Obesity [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]Obesidad abdominalGeographical LocationsGlucose MetabolismRisk FactorsHábito de fumarMedicine and Health SciencesPrevalence030212 general & internal medicinePrediabetes:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [Medical Subject Headings]Multidisciplinary:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Chronic Disease [Medical Subject Headings]DiabetesMiddle Aged:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies [Medical Subject Headings]EuropeEncuestas y cuestionariosPhysiological ParametersResearch DesignCarbohydrate MetabolismFemaleResearch ArticleAdultAdolescent030209 endocrinology & metabolismVida sedentariaResearch and Analysis MethodsHDL-colesterolYoung AdultSex FactorsDiabetes mellitusmedicineAdultsObesityEspanya:Diseases::Endocrine System Diseases::Diabetes Mellitus::Prediabetic State [Medical Subject Headings]Sedentary lifestylebusiness.industryEstado prediabéticoBody WeightPhysical fitnessDieta mediterráneaMetabolisme dels lípidsDietMetabolismSpainMetabolic DisordersPeople and PlacesPhysical therapySedentary BehaviorbusinessPrevalenciaCondició física
researchProduct

Evaluación de la influencia de la aplicación del algoritmo terapéutico de la Dislipemia de la Generalitat Valenciana en el gasto farmacológico hipoli…

2020

La enfermedad cardiovascular (ECV) es la mayor causa de muerte prematura y discapacidad ajustada por años de vida en Europa y su frecuencia aumenta en los países en desarrollo. En la Unión Europea, el coste económico de la ECV representa un gasto anual muy elevado derivado de los costes sanitarios tanto directos como indirectos. Las entidades clínicas más importantes son la enfermedad coronaria, los accidentes cerebro-vasculares isquémicos y la enfermedad arterial (coronaria y periférica). La forma más coste-efectiva de controlar la importante carga sanitaria y de mortalidad de las enfermedades cardiovasculares consiste en reducir su incidencia reduciendo la prevalencia de los factores que …

Riesgo cardiovascularDislipemiaUNESCO::CIENCIAS MÉDICASAlgoritmo Generalitat ValencianaEnfermedades cardiovascularesGasto sanitario:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Estudio comparativo del efecto de diferentes fármacos antirretrovirales sobre la interacción leucocito-endotelio

2016

La “Terapia Antirretroviral Combinada”, se basa en la administración de al menos 3 fármacos: 2 ITIAN en combinación con 1 antagonista CCR5, 1 ITINAN, 1 InInt o 1 IP. Con su empleo han aparecido efectos adversos, teniendo las enfermedades cardiovasculares una incidencia del 15,7 % en estos pacientes, sin embargo, se desconoce el papel que tiene cada fármaco ya se administran en combinación. El objetivo del presente estudio fue realizar un estudio sistemático de los efectos proinflamatorios de concentraciones clínicamente relevantes de MVC (antagonista CCR5), EFV, NVP y RPV (ITINAN), RAL (InInt), LPV, ATV y DRV (IP) sobre el primer paso en el desarrollo de enfermedades cardiovasculares con co…

interacción leucocito-endotelioUNESCO::CIENCIAS MÉDICASenfermedades cardiovascularesfármacos Antirretroviralesproceso Inflamatorio:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020

2020

The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: Epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; Cardiovascular (CV) risk tables and recommendations for the calculation of CV risk; Main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; Indications for antiplatelet therapy, a…

medicine.medical_specialtyFamily medicineMedicina:Health Care::Environment and Public Health::Public Health::Epidemiologic Factors::Causality::Risk Factors [Medical Subject Headings]030204 cardiovascular system & hematologyPharmacological treatment:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings]03 medical and health sciences0302 clinical medicineDiabetes mellitusDiabetes mellitusEpidemiologymedicine030212 general & internal medicineIntensive care medicine:Diseases::Cardiovascular Diseases [Medical Subject Headings]lcsh:R5-920:Diseases::Endocrine System Diseases::Diabetes Mellitus [Medical Subject Headings]business.industryMedicina de familia:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style [Medical Subject Headings]Atrial fibrillationGeneral MedicineAtención primariamedicine.diseasePrimary careCardiovasculardiseasesHealth promotionCardiovascular diseases:Health Care::Health Care Facilities Manpower and Services::Health Promotion [Medical Subject Headings]Preventive activitiesEnfermedades cardiovasculareslcsh:Medicine (General)Family PracticebusinessDyslipidemia
researchProduct